Feng Zhang

6PUBLICATIONS
15CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 02, 2024
Activation of NOD1 on tumor-associated macrophages augments CD8+ T cell-mediated antitumor immunity in hepatocellular carcinoma.

Feng Zhang, Qiuyu Jiang, Jialiang Cai

|Sep 03, 2024
Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma.

Jialiang Cai, Lina Song, Feng Zhang

|Jul 16, 2024
CD276 Promotes an Inhibitory Tumor Microenvironment in Hepatocellular Carcinoma and is Associated with Poor Prognosis.

Wen-Feng Liu, Qiu-Yu Jiang, Zhuo-Ran Qi

|Dec 23, 2022
PVR-A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.

Wen-Feng Liu, Bing Quan, Miao Li

|Nov 29, 2021
The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.

Wenfeng Liu, Feng Zhang, Bing Quan

|Jan 05, 2021
Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy.

Feng Zhang, Shen-Xin Lu, Ke-Shu Hu

Pageof 1

Frequent Collaborators

2 joint publications

Xin Yin

2 joint publications

Wenfeng Liu

1 joint publications

Bing Quan

1 joint publications

Miao Li